Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Chubb
Healthtrust
Teva
Dow
McKinsey
Cipla
Moodys

Generated: December 17, 2018

DrugPatentWatch Database Preview

LUZU Drug Profile

« Back to Dashboard

When do Luzu patents expire, and when can generic versions of Luzu launch?

Luzu is a drug marketed by Medicis and is included in one NDA. There are five patents protecting this drug.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in LUZU is luliconazole. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the luliconazole profile page.

Summary for LUZU
International Patents:64
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 41
Patent Applications: 23
Drug Prices: Drug price information for LUZU
DailyMed Link:LUZU at DailyMed
Drug patent expirations by year for LUZU
Generic Entry Opportunity Date for LUZU
Generic Entry Date for LUZU*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
CREAM;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for LUZU
Synonyms for LUZU
(-)-(E)-((4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
(R,E)-2-(4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile
164L198
187164-19-8
1H-Imidazole-1-acetonitrile, alpha-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-, (alphaE)-
2-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile
4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene-1-imidazolylacetonitrile
AC1MHEOF
AKOS015897320
AM84645
AN-15036
BCP9000863
C13478
CAS-187164-19-8
CHEBI:34825
CHEMBL2105689
CS-0587
D01980
D0U4XJ
DB08933
DSSTox_CID_28533
DSSTox_GSID_48607
DSSTox_RID_82805
DTXSID3048607
GTPL7366
HE064141
HE320898
HY-14283
Imidazole antimycotic
JA-004
JA-005
Lulicon
Lulicon (TN)
Lulicon|||NND 502
Luliconazole
Luliconazole (JAN/USAN/INN)
Luliconazole [USAN:INN]
Luliconazole, >=98% (HPLC)
Lulifin
Luzu (TN)
MFCD00953915
MolPort-035-395-835
NCGC00182704-01
NCGC00182704-02
NCGC00182704-03
NND 502
NND-502
NND502
PR-2699
RE91AN4S8G
s4258
SCHEMBL342362
SR-01000945039
SR-01000945039-1
Tox21_112942
Tox21_112974
Tox21_112974_1
UNII-5JA16R08FJ component YTAOBBFIOAEMLL-REQDGWNSSA-N
UNII-RE91AN4S8G
W-5249
ZINC3929486

US Patents and Regulatory Information for LUZU

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Chubb
Healthtrust
Teva
Dow
McKinsey
Cipla
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.